Ledger.Open graph →
SEC Form D · filed March 3, 2025

SciSparc Ltd

Offering
$4.2M
Sold
$4.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
TEL AVIV, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Moshe Revach · Tel Aviv, L3DirectorLiat Sidi · Tel Aviv, L3DirectorLior Vider · Tel Aviv, L3DirectorOz Adler · Tel Aviv, L3ExecAmitay Weiss · Tel Aviv, L3DirectorDr. Adi Zuloff-Shani · Tel Aviv, L3ExecItschak Shrem · Tel Aviv, L3Exec · DirectorAmnon Ben Shay · Tel Aviv, L3DirectorAlon Dayan · Tel Aviv, L3DirectorAlon Dayan · Tel Aviv, L3DirectorAmnon Ben Shay · Tel Aviv, L3DirectorMoshe Revach · Tel Aviv, L3DirectorAmitay Weiss · Tel Aviv, L3DirectorOz Adler · Tel Aviv, L3ExecLiat Sidi · Tel Aviv, L3DirectorItschak Shrem · Tel Aviv, L3Exec · DirectorLior Vider · Tel Aviv, L3DirectorDr. Adi Zuloff-Shani · Tel Aviv, L3ExecChuck Harris · Doylestown, PADirectorRyan Keane · Doylestown, PADirectorB. Bobby Bahram · Doylestown, PADirectorHugh R. Roome · Doylestown, PADirectorScott D. Mackes · Mt Pleasant, SCExec · DirectorBrian D. Whitten · Austin, TXExecDavid Blivin · Albuquerque, NMDirectorEric Pawlowski · Boston, MADirectorLee Garber · Radnor, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗